Using this threshold, the probability of having a pathological NAFLD-LFS score in women with SHBG <33.4 or >= 33.4 nmol/L was 47.8% and 12.1%, respectively (p=0.003). Here, SHBG is linked to metabolic dysfunction-associated steatotic liver disease.